Lack of Benefit on Treating Asymptomatic Bacteriuria Prior to Cardiovascular Surgery: a Systematic Review and Meta-Analysis
[...]in the cardiovascular surgery context there is few evidence about the impact of ASB in the SSI rate, this last has a reported incidence of 1%-10% and confers affected individuals a high risk of mortality, which can reach up to 25% in cases of deep SSI[5,6]. Because of this, there is a substanti...
Saved in:
Published in | Revista brasileira de cirurgia cardiovascular Vol. 33; no. 6; pp. 641 - 643 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Brazil
Sociedade Brasileira de Cirurgia Cardiovascular
2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | [...]in the cardiovascular surgery context there is few evidence about the impact of ASB in the SSI rate, this last has a reported incidence of 1%-10% and confers affected individuals a high risk of mortality, which can reach up to 25% in cases of deep SSI[5,6]. Because of this, there is a substantial need of evaluating the potential role of ASB, in order to create optimal recommendations for the SSI prevention in these patients. The literature search was performed by two authors using the databases Medline, Embase, PubMed, EBSCOHost, SciELO, LILACS and the Cochrane Central Register of Controlled Trials using the following terms: asymptomatic bacteriuria; bacteriuria; nitrites; pyuria; asymptomatic leukocyturia; urine analysis; urinalysis; cardiac surgery; heart surgery; cardiovascular surgery; cardiothoracic surgery. Eligible studies corresponded to randomized controlled trials, cohorts and case-control studies that evaluated the benefit of treating ASB in patients taken to cardiovascular surgery. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 ObjectType-Correspondence-3 content type line 23 ObjectType-Undefined-4 |
ISSN: | 1678-9741 0102-7638 1678-9741 |
DOI: | 10.21470/1678-9741-2018-0276 |